Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Hualan Biological Engineering (002007 CH)
Watchlist
41
Analysis
Health Care
•
China
Hualan Biological Engineering Inc. produces and markets human serum albumin (HSA), gamma globulin, frozen prothrombin (PCC), and other related biological products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Shanghai RAAS Blood Products C
•
25 Jan 2024 08:55
Haier Group to Buy $1.8B Stake in Shanghai RAAS from Grifols – A New Chapter Begins
We analyzed the key points/logic behind Haier's decision to acquire Shanghai RAAS from Grifols. Despite potential risks, it is still a wise move...
Xinyao (Criss) Wang
Follow
465 Views
Share
bearish
•
Thematic (Sector/Industry)
•
07 Aug 2023 13:00
Anti-Corruption in China Healthcare – the Impact and the Outlook
The share prices of China healthcare are now plummeting due to anti-corruption campaign, which will reach a climax in 23H2 (We'll post updates in...
Xinyao (Criss) Wang
Follow
691 Views
Share
bearish
•
Clover Biopharmaceuticals
•
11 Jun 2023 09:27
China Healthcare Weekly (Jun.9) - Pediatric TCM New Policy, Long-Term Money Dislikes A-Share, Clover
New policy for pediatric TCM is released,indicating good growth potential.Long-term money dislike A-share,mainly due to concerns on growth not...
Xinyao (Criss) Wang
Follow
316 Views
Share
bearish
•
Quantitative Analysis
•
09 Apr 2023 10:15
Northbound Flows (Apr 6th): East Money, Muyuan Foods, CTG, Ping An Insurance, Hundsun, CMB, Foxconn
We analyzed the Shanghai/Shenzhen Connect Scheme for last week and highlight flows for East Money, Muyuan Foods, CTG, Ping An Insurance, Hundsun,...
Ke Yan, CFA, FRM
Follow
383 Views
Share
bullish
•
Beijing Tiantan Biological Products
•
30 Nov 2022 08:34
Beijing Tiantan Biological Products (600161CH)-A Good Defensive Investment Target but May Overvalued
Tiantan is a good defensive target in unfriendly external macro due to its advantageous background, but performance growth would slow down in 2022....
Xinyao (Criss) Wang
Follow
294 Views
Share
1
2
3
4
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.4
x